Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 681,153 |
|
|||||
| News | - | ||||||
| Day High | 55.92 | Low High |
|||||
| Day Low | 53.92 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Merus NV | MRUS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -1.53 | -2.74% | 54.24 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 55.76 | 53.92 | 55.92 | 54.24 | 55.77 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,844 | 681,153 | US$ 54.88 | US$ 37,382,075 | - | 19.805 - 61.61 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:33:28 | priorref | 84,239 | US$ 54.24 | USD |
Merus NV Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 0 | 57.88M | - | 43.95M | -154.94M | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Merus NV News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRUS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 53.25 | 59.66 | 53.25 | 56.91 | 1,009,862 | 0.99 | 1.86% |
| 1 Month | 43.41 | 61.61 | 42.60 | 54.74 | 1,670,411 | 10.83 | 24.95% |
| 3 Months | 45.11 | 61.61 | 39.27 | 50.18 | 970,311 | 9.13 | 20.24% |
| 6 Months | 25.42 | 61.61 | 24.815 | 45.97 | 758,267 | 28.82 | 113.38% |
| 1 Year | 25.99 | 61.61 | 19.805 | 39.10 | 543,534 | 28.25 | 108.70% |
| 3 Years | 21.05 | 61.61 | 12.03 | 29.96 | 397,770 | 33.19 | 157.67% |
| 5 Years | 13.37 | 61.61 | 10.18 | 28.00 | 283,398 | 40.87 | 305.68% |
Merus NV Description
| Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics. Merus only reportable segment comprising the discovery and development of innovative bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others. |
